Epstein-Barr virus-associated Hodgkin's disease in a patient with Wiskott-Aldrich syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 90, Issue 11, 2001, Pages 1348-1351

  Sasahara, Y ^a   Fujie, H ^a   Kumaki, S ^a   Ohashi, Y ^a   Minegishi, M ^b   Tsuchiya, S ^a   Johnston, S L ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Epstein Barr virus; Hodgkin's disease; Latent membrane protein 1; Wiskott Aldrich syndrome

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; LATENT MEMBRANE PROTEIN 1; VINBLASTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD; WISKOTT ALDRICH SYNDROME;

HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; VIRAL MATRIX PROTEINS; WISKOTT-ALDRICH SYNDROME;

EID: 0035210857     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2001.tb01589.x     Document Type: Article

References (24)

1. Recent advances in our understanding of Wiskott-Aldrich syndrome
2. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
3. A multi-institutional survey of the Wiskott-Aldrich syndrome
4. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
5. The Epstein-Barr virus transforming protein LMP1 engages signaling protein for the tumor necrosis factor receptor family
6. Tumor necrosis factor receptor-associated factor 1 is over-expressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells
7. The Epstein-Barr virus latent membrane protein-1 (LMP-1) mediates activation of NFB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
8. Latent membrane protein I of Epstein-Barr vires interacts with JAK3 and STAT protein
9. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center
10. Epstein-Barr virus-associated lymphoproliferative disorder after bone marrow transplantation in a young child with Wiskott-Aldrich syndrome
11. Hodgkin's disease occurring in a patient with the Wiskott-Aldrich syndrome
12. Disseminated nasal T cell lymphoma with a partial deletion of the LMP1 oncogene in a patient with chronic active Epstein-Barr virus infection
13. Hodgkin's disease
14. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders
15. Epstein-Barr virus in Hodgkin's disease: Frequency of a 30-bp deletion in the latent membrane protein 1 (LMP-1) oncogene in South African patients
16. High prevalence of Epstein-Barr virus type A strain with the 30 bp deletion of the latent membrane protein-1 gene in a Japanese population
17. The association of the Epstein-Barr virus with malignant lymphoma
18. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
19. Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions
20. Local suppression of Epstein-Barr virus-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
21. Infusion of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation
22. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells
23. Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease
24. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs